Novartis (NVS) Short Interest Ratio & Short Volume $97.11 +0.34 (+0.35%) (As of 12/20/2024 04:33 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Novartis Short Interest DataNovartis (NVS) has a short interest of 4.49 million shares, representing 0.23% of the float (the number of shares available for trading by the public). This marks a -6.26% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.0, indicating that it would take 4.0 days of the average trading volume of 1.33 million shares to cover all short positions.Current Short Interest4,490,000 sharesPrevious Short Interest4,790,000 sharesChange Vs. Previous Month-6.26%Dollar Volume Sold Short$474.91 millionShort Interest Ratio4.0 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares2,044,000,000 sharesFloat Size1,960,000,000 sharesShort Percent of Float0.23%Today's Trading Volume1,547,658 sharesAverage Trading Volume1,326,035 sharesToday's Volume Vs. Average117% Short Selling Novartis? Sign up to receive the latest short interest report for Novartis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNVS Short Interest Over TimeNVS Days to Cover Over TimeNVS Percentage of Float Shorted Over Time Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Novartis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20244,490,000 shares $474.91 million -6.3%0.2%4 $105.77 11/15/20244,790,000 shares $493.66 million +0.6%0.2%4.2 $103.06 10/31/20244,760,000 shares $515.89 million -0.6%0.2%4.5 $108.38 10/15/20244,790,000 shares $556.79 million -16.0%0.2%4.7 $116.24 9/30/20245,700,000 shares $655.67 million +7.1%0.3%4.9 $115.03 9/15/20245,320,000 shares $615.31 million -6.7%0.3%4.4 $115.66 Get the Latest News and Ratings for NVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novartis and its competitors with MarketBeat's FREE daily newsletter. 8/31/20245,700,000 shares $689.07 million -2.9%0.3%4.5 $120.89 8/15/20245,870,000 shares $665.25 million +4.6%0.3%4.5 $113.33 7/31/20245,610,000 shares $625.46 million -10.0%0.3%4.2 $111.49 7/15/20246,230,000 shares $687.36 million -0.2%0.3%4.2 $110.33 6/30/20246,240,000 shares $664.31 million -0.6%0.3%4.3 $106.46 6/15/20246,280,000 shares $663.92 million +60.2%0.3%4.1 $105.72 5/31/20243,920,000 shares $404.27 million -23.6%0.2%2.6 $103.13 5/15/20245,130,000 shares $529.52 million +21.6%0.3%3.3 $103.22 4/30/20244,220,000 shares $409.89 million +10.8%0.2%2.7 $97.13 4/15/20243,810,000 shares $359.66 million -9.5%0.2%2.4 $94.40 3/31/20244,210,000 shares $407.23 million +1.5%0.2%2.9 $96.73 3/15/20244,150,000 shares $403.71 million -8.4%0.2%3 $97.28 2/29/20244,530,000 shares $457.17 million +10.0%0.2%3.1 $100.92 2/15/20244,120,000 shares $410.39 million +5.9%0.2%2.8 $99.61 1/31/20243,890,000 shares $402.58 million -10.4%0.2%2.7 $103.49 1/15/20244,340,000 shares $466.33 million +15.1%0.2%2.8 $107.45 12/31/20233,770,000 shares $380.66 million +5.9%0.2%2.3 $100.97 12/15/20233,560,000 shares $346.74 million +4.7%0.2%2.2 $97.40 11/30/20233,400,000 shares $332.83 million -11.5%0.2%2.2 $97.89 11/15/20233,840,000 shares $360.19 million +5.2%0.2%2.6 $93.80 10/31/20233,650,000 shares $341.57 million +13.4%0.2%2.7 $93.58 10/15/20233,220,000 shares $313.11 million -19.1%0.2%2.6 $97.24 9/30/20233,980,000 shares $405.40 million +2.1%0.2%3.2 $101.86 9/15/20233,900,000 shares $400.26 million -2.5%0.2%3 $102.63 8/31/20234,000,000 shares $401.92 million +2.8%0.2%2.8 $100.48 8/15/20233,890,000 shares $399.08 million +2.6%0.2%2.2 $102.59 7/31/20233,790,000 shares $397.57 million +1.3%0.2%2 $104.90 7/15/20233,740,000 shares $369.62 million -2.6%0.2%1.9 $98.83 6/30/20233,840,000 shares $387.42 million -7.0%0.2%1.9 $100.89 6/15/20234,130,000 shares $418.70 million -5.7%0.2%2 $101.38 5/31/20234,380,000 shares $421.53 million +2.3%0.2%1.9 $96.24 5/15/20234,280,000 shares $441.35 million -10.5%0.2%2.1 $103.12 4/30/20234,780,000 shares $490.28 million -13.1%0.2%2.3 $102.57 4/15/20235,500,000 shares $538.34 million -13.1%0.3%2.5 $97.88Your chance to get on the next “60-Second Trade” (Ad)Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! 3/31/20236,330,000 shares $582.36 million No Change0.3%2.8 $92.00 3/15/20236,330,000 shares $519.69 million -4.1%0.3%3.1 $82.10 2/28/20236,600,000 shares $555.19 million +2.5%0.3%3.4 $84.12 2/15/20236,440,000 shares $561.44 million +16.9%0.3%3.3 $87.18 1/31/20235,510,000 shares $499.32 million +3.6%0.3%2.7 $90.62 1/15/20235,320,000 shares $484.44 million +11.1%0.2%2.6 $91.06 12/30/20224,790,000 shares $434.55 million -10.6%0.2%2.4 $90.72 12/15/20225,360,000 shares $487.17 million +1.3%0.2%2.5 $90.89 11/30/20225,290,000 shares $473.77 million +0.6%0.2%2.4 $89.56 11/15/20225,260,000 shares $440.95 million -14.1%0.2%2.1 $83.83 10/31/20226,120,000 shares $496.52 million +0.7%0.3%2.6 $81.13 10/15/20226,080,000 shares $459.47 million +6.3%0.3%2.6 $75.57 9/30/20225,720,000 shares $434.78 million +2.3%0.3%2.4 $76.01 9/15/20225,590,000 shares $451.34 million -1.2%0.3%2.6 $80.74 8/31/20225,660,000 shares $455.74 million -10.7%0.3%2.6 $80.52 8/15/20226,340,000 shares $541.31 million +4.1%0.3%3.2 $85.38 7/31/20226,090,000 shares $522.70 million +1.2%0.3%2.7 $85.83 7/15/20226,020,000 shares $509.53 million +0.5%N/A2.6 $84.64 6/30/20225,990,000 shares $506.33 million -4.0%N/A2.5 $84.53 6/15/20226,240,000 shares $507.69 million +4.5%N/A2.6 $81.36 5/31/20225,970,000 shares $542.91 million -15.7%0.3%2.4 $90.94 5/15/20227,080,000 shares $607.61 million +10.8%0.3%2.7 $85.82 4/30/20226,390,000 shares $562.51 million -2.6%0.3%2.4 $88.03 4/15/20226,560,000 shares $606.93 million +6.7%0.3%2.4 $92.52 3/31/20226,150,000 shares $539.66 million -2.2%0.3%2.3 $87.75 3/15/20226,290,000 shares $532.95 million +10.7%0.3%2.3 $84.73 2/28/20225,680,000 shares $496.77 million +4.0%0.3%2 $87.46 2/15/20225,460,000 shares $471.85 million -25.9%0.2%2 $86.42 1/31/20227,370,000 shares $640.53 million +12.7%0.3%2.9 $86.91 1/15/20226,540,000 shares $592.20 million -11.4%0.3%2.6 $90.55 12/31/20217,380,000 shares $645.53 million +39.0%0.3%3.1 $87.47 12/15/20215,310,000 shares $432.87 million -20.5%0.2%2.2 $81.52 11/30/20216,680,000 shares $532.40 million +8.6%0.3%3.1 $79.70 11/15/20216,150,000 shares $506.02 million +3.7%0.3%2.9 $82.28 10/29/20215,930,000 shares $490.77 million +8.2%0.3%2.8 $82.76 10/15/20215,480,000 shares $456.65 million -3.0%0.3%2.8 $83.33 9/30/20215,650,000 shares $462.06 million +0.9%0.3%2.9 $81.78 9/15/20215,600,000 shares $476.45 million +16.7%0.3%3.1 $85.08 8/31/20214,800,000 shares $443.47 million +4.1%0.2%2.8 $92.39 8/13/20214,610,000 shares $432.56 million +0.2%0.2%2.7 $93.83 7/30/20214,600,000 shares $424.99 million -19.6%0.2%2.7 $92.39 7/15/20215,720,000 shares $521.95 million -13.9%0.3%3.2 $91.25 6/30/20216,640,000 shares $605.83 million +0.5%0.3%3.7 $91.24 6/15/20216,610,000 shares $620.75 million +0.9%0.3%3.5 $93.91 5/28/20216,550,000 shares $578.89 million +3.3%0.3%3.5 $88.38 5/14/20216,340,000 shares $560.46 million +2.6%0.3%3.5 $88.40 4/30/20216,180,000 shares $531.67 million -11.2%0.3%3.3 $86.03 4/15/20216,960,000 shares $603.78 million +6.9%0.3%3.5 $86.75 3/31/20216,510,000 shares $566.50 million +0.3%0.3%3.2 $87.02 3/15/20216,490,000 shares $546.00 million -3.1%0.3%3.3 $84.13Your chance to get on the next “60-Second Trade” (Ad)Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! 2/26/20216,700,000 shares $580.96 million +29.1%0.3%3.4 $86.71 2/12/20215,190,000 shares $478.47 million -3.0%0.2%2.5 $92.19 1/29/20215,350,000 shares $496.69 million -16.1%0.2%2.6 $92.84 1/15/20216,380,000 shares $603.68 million +44.0%0.3%3.1 $94.62 12/31/20204,430,000 shares $418.01 million +0.9%0.2%2.4 $94.36 12/15/20204,390,000 shares $397.51 million +10.6%0.2%2.3 $90.55 11/30/20203,970,000 shares $356.35 million +22.5%0.2%2.1 $89.76 11/15/20203,240,000 shares $278.96 million -23.0%0.2%1.7 $86.10 10/30/20204,210,000 shares $328.67 million +29.9%0.2%2.3 $78.07 10/15/20203,240,000 shares $283.27 million +39.7%0.2%1.9 $87.43 9/30/20202,320,000 shares $201.75 million -6.1%0.1%1.3 $86.96 9/15/20202,470,000 shares $224.77 million +14.9%0.1%1.5 $91.00 8/31/20202,150,000 shares $185.03 million +3.4%0.1%1.3 $86.06 8/14/20202,080,000 shares $176.07 million +18.2%0.1%1.2 $84.65 7/31/20201,760,000 shares $144.57 million -12.0%0.1%1 $82.14 7/15/20202,000,000 shares $174.94 million -3.9%0.1%1.1 $87.47 6/30/20202,080,000 shares $181.67 million +28.4%0.1%1.1 $87.34 6/15/20201,620,000 shares $137.96 million -36.7%0.1%0.8 $85.16 5/29/20202,560,000 shares $223.82 million +6.7%0.1%1 $87.43 5/15/20202,400,000 shares $201.65 million -14.9%0.1%0.8 $84.02 4/30/20202,820,000 shares $238.94 million -8.1%0.1%1 $84.73 4/15/20203,070,000 shares $262.82 million +10.8%0.1%1.1 $85.61 3/31/20202,770,000 shares $246.67 million -6.4%0.1%1 $89.05 3/13/20202,958,300 shares $251.01 million +10.8%0.1%1.3 $84.85 2/28/20202,670,000 shares $188.69 million -18.4%0.1%1.2 $70.67 2/14/20203,270,000 shares $277.79 million -18.9%0.1%1.7 $84.95 1/31/20204,030,000 shares $351.05 million +10.4%0.2%2.5 $87.11 1/15/20203,650,000 shares $358.54 million +17.7%0.2%2.3 $98.23 12/31/20193,100,000 shares $291.00 million -11.7%0.1%2 $93.87 NVS Short Interest - Frequently Asked Questions What is Novartis' current short interest? Short interest is the volume of Novartis shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 4,490,000 shares of NVS short. 0.23% of Novartis' shares are currently sold short. Learn More on Novartis' current short interest. What is a good short interest ratio for Novartis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVS shares currently have a short interest ratio of 4.0. Learn More on Novartis's short interest ratio. Which institutional investors are shorting Novartis? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Novartis: Barclays PLC, Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Readystate Asset Management LP, Point72 Asset Management L.P., Walleye Trading LLC, Walleye Capital LLC, Belvedere Trading LLC, Genus Capital Management Inc., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Novartis? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.23% of Novartis' floating shares are currently sold short. Is Novartis' short interest increasing or decreasing? Novartis saw a decline in short interest in November. As of November 30th, there was short interest totaling 4,490,000 shares, a decline of 6.3% from the previous total of 4,790,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Novartis' float size? Novartis currently has issued a total of 2,044,000,000 shares. Some of Novartis' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Novartis currently has a public float of 1,960,000,000 shares. How does Novartis' short interest compare to its competitors? 0.23% of Novartis' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Novartis: Novo Nordisk A/S (0.13%), AstraZeneca PLC (0.24%), Sanofi (0.18%), GSK plc (0.95%), Takeda Pharmaceutical Company Limited (0.15%), BioNTech SE (0.99%), Teva Pharmaceutical Industries Limited (1.98%), BeiGene, Ltd. (1.36%), Moderna, Inc. (11.90%), Viatris Inc. (1.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Novartis stock? Short selling NVS is an investing strategy that aims to generate trading profit from Novartis as its price is falling. NVS shares are trading up $0.34 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Novartis? A short squeeze for Novartis occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NVS, which in turn drives the price of the stock up even further. How often is Novartis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVS, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Novo Nordisk A/S Short Interest AstraZeneca Short Interest Sanofi Short Interest GSK Short Interest Takeda Pharmaceutical Short Interest BioNTech Short Interest Teva Pharmaceutical Industries Short Interest BeiGene Short Interest Moderna Short Interest Viatris Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:NVS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
